John E. Davis - 31 Dec 2025 Form 5 Insider Report for ARTIVION, INC. (AORT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
5
Accepted by SEC
28 Jan 2026, 15:50:54 UTC
Prior SEC filing
17 Dec 2025
Next SEC filing
25 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John E. Davis

Key filing fact

John E. Davis filed Form 5 for ARTIVION, INC. (AORT) on 28 Jan 2026.

Key facts

  • This page summarizes John E. Davis's Form 5 filing for ARTIVION, INC. (AORT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Jan 2026, 15:50.

Change

  • Previous filing in this sequence was filed on 17 Dec 2025.
  • Current net transaction value: +$21,240.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reporting Owners (1)

CIK 0001653206 Primary reporting owner

Davis John E

Relationship
Chief Commercial Officer
Address
1655 ROBERTS BLVD., NW, KENNESAW
Signature
/s/ John E. Davis
Signature date
28 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Award

Transaction value
$21,240
Shares
+874
Change %
+0.45%
Price
$24.30
Shares after
194,716
Date
30 Jun 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .